Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies.

Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag (2010) 1.24

The accuracy of self-reported drug ingestion histories in emergency department patients. J Clin Pharmacol (2014) 1.11

Receipt of diabetes preventive services differs by insurance status at visit. Am J Prev Med (2014) 0.92

Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps. Exp Diabetes Res (2010) 0.87

Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus. Mayo Clin Proc (2011) 0.87

Primary care of patients with high cardiovascular risk : Blood pressure, lipid and diabetic target levels and their achievement in Hungary. Wien Klin Wochenschr (2013) 0.82

Diabetes preventive services and policy implications in the U.S. Diabetes Care (2010) 0.77

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics. Diabetes Metab Syndr Obes (2010) 0.76

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 95.79

Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76

10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med (2008) 35.49

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (1998) 32.73

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77

Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med (2003) 20.06

Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med (2008) 19.76

Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med (2008) 18.27

Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet (2007) 14.96

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens (2003) 11.32

Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med (2008) 8.82

Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med (2007) 6.09

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care (2008) 5.43

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care (2007) 4.30

Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Am J Cardiol (2006) 3.17

Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). Am Heart J (2007) 3.12

Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol (2005) 2.81

Hyperglycemia and its effect after acute myocardial infarction on cardiovascular outcomes in patients with Type 2 diabetes mellitus (HEART2D) Study design. J Diabetes Complications (2005) 2.64

ALLHAT: setting the record straight. Ann Intern Med (2004) 2.19

UKPDS and the legacy effect. N Engl J Med (2008) 1.49

Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study. BMJ (1991) 1.44

Glycemic targets and cardiovascular disease. N Engl J Med (2008) 1.42

Reducing cardiovascular risk in type 2 diabetes. N Engl J Med (2003) 1.29

Redefining quality--implications of recent clinical trials. N Engl J Med (2008) 1.14

The Multiple Risk Factor Intervention Trial (MRFIT)--importance then and now. JAMA (2008) 1.03

New treatment guidelines for a patient with diabetes and hypertension. J Hypertens Suppl (2003) 1.01

Thiazide diuretics in the treatment of hypertension: an update. J Am Soc Nephrol (2006) 0.96

Comparative safety of newer oral antidiabetic drugs. Expert Opin Drug Saf (2006) 0.81

ACCORD and ADVANCE: a tale of two studies on the merits of glycaemic control in type 2 diabetic patients. Nephrol Dial Transplant (2008) 0.80

Target intervention against multiple-risk markers to reduce cardiovascular disease in patients with type 2 diabetes. Ann Med (2004) 0.79

New ADVANCEs in guidelines. J Hypertens Suppl (2008) 0.77

What have we learned from the HOT (Hypertension Optimal Treatment) study? Nephrol Dial Transplant (1997) 0.77

Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA (2003) 3.39

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. Blood (2013) 3.03

Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood (2007) 2.82

Predictors of overweight during childhood in offspring of parents with type 1 diabetes. Diabetes Care (2009) 2.31

Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat Immunol (2005) 2.31

Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet (2012) 2.07

New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood (2008) 1.97

Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat Med (2010) 1.93

Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One (2011) 1.87

The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood (2013) 1.71

Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations. Genes Dev (2011) 1.69

Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature (2013) 1.66

Hodgkin's lymphoma: biology and treatment strategies for primary, refractory, and relapsed disease. Hematology Am Soc Hematol Educ Program (2003) 1.56

IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL. Blood (2013) 1.55

Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood (2008) 1.47

Depsipeptide induces cell death in Hodgkin lymphoma-derived cell lines. Leuk Res (2009) 1.47

Primary and secondary prevention of cardiovascular disease in diabetes with aspirin. Diab Vasc Dis Res (2012) 1.45

PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A (2013) 1.44

Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma. Proc Natl Acad Sci U S A (2009) 1.44

Ocular adnexal lymphomas: five case presentations and a review of the literature. Surv Ophthalmol (2002) 1.43

Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood (2011) 1.39

Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study. Diabetes Care (2011) 1.38

Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome. Graefes Arch Clin Exp Ophthalmol (2003) 1.37

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL. Blood (2010) 1.33

Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood (2005) 1.30

IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes. Diabetes Care (2004) 1.29

Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma. Blood (2012) 1.27

Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells. Blood (2005) 1.24

Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. Blood (2004) 1.23

Macrophage development from HSCs requires PU.1-coordinated microRNA expression. Blood (2011) 1.22

Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma. PLoS One (2011) 1.22

Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study. J Clin Oncol (2010) 1.21

Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells. J Pathol (2003) 1.19

Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma. Haematologica (2008) 1.15

Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases. J Pathol (2002) 1.13

Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas. J Pathol (2004) 1.12

Primary intraocular lymphoma of T-cell type: report of a case and review of the literature. Graefes Arch Clin Exp Ophthalmol (2004) 1.12

CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells. Am J Pathol (2008) 1.11

CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation. J Pathol (2004) 1.11

CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. J Clin Pathol (2006) 1.08

Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity. Haematologica (2010) 1.07

Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status. Genes Chromosomes Cancer (2009) 1.06

Molecular analysis of immunoglobulin genes in primary intraocular lymphoma. Invest Ophthalmol Vis Sci (2005) 1.06

5,5'-Azoxytetrazolates--a new nitrogen-rich dianion and its comparison to 5,5'-azotetrazolate. Dalton Trans (2012) 1.06

Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma. Haematologica (2013) 1.05

Molecular profiles and clinical outcome of stage UICC II colon cancer patients. Int J Colorectal Dis (2011) 1.05

Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles. BMC Cancer (2010) 1.03

Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer. BMC Genomics (2010) 1.01

MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma. Cancer Med (2012) 1.01

Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies. BMC Mol Biol (2008) 1.00

Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria. J Thorac Oncol (2014) 0.98

A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood (2014) 0.98

Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy. J Am Coll Cardiol (2005) 0.98

Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testing. Lung Cancer (2013) 0.97

Genomic loss of the putative tumor suppressor gene E2A in human lymphoma. J Exp Med (2011) 0.97

Frequency and diagnostic patterns of lymphomas in liver biopsies with respect to the WHO classification. Virchows Arch (2007) 0.96

Hypermutation of the inactive X chromosome is a frequent event in cancer. Cell (2013) 0.96

Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors. Blood (2007) 0.96

Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas. Neuro Oncol (2011) 0.96

Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis. Haematologica (2010) 0.93

Diversification of Ig heavy chain genes in human preterm neonates prematurely exposed to environmental antigens. J Immunol (2002) 0.93

Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes. J Clin Oncol (2006) 0.92

Expression of functional T-cell markers and T-cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy. Eur J Heart Fail (2011) 0.91

High Myc activity is an independent negative prognostic factor for diffuse large B cell lymphomas. Int J Cancer (2011) 0.91

Cloning and expression of an inhibitor of microbial metalloproteinases from insects contributing to innate immunity. Biochem J (2004) 0.90

Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin. Blood (2002) 0.90

Gene expression profiling: cell cycle deregulation and aneuploidy do not cause breast cancer formation in WAP-SVT/t transgenic animals. J Mol Med (Berl) (2005) 0.89

Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials. Haematologica (2009) 0.88

Epstein-barr virus infection of monocytoid B-cell proliferates: an early feature of primary viral infection? Am J Surg Pathol (2005) 0.87

Defective tight junctions in refractory celiac disease. Ann N Y Acad Sci (2012) 0.87

HHV-8-associated T-cell lymphoma in a lymph node with concurrent peritoneal effusion in an HIV-positive man. Am J Surg Pathol (2005) 0.87

The postnatal maturation of the immunoglobulin heavy chain IgG repertoire in human preterm neonates is slower than in term neonates. J Immunol (2007) 0.87

Induced pluripotent stem cells expressing elevated levels of sox-2, oct-4, and klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells. Stem Cells Dev (2011) 0.87

Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma. J Cancer Res Clin Oncol (2014) 0.86

NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy. PLoS One (2008) 0.86

First-in-man clinical results with good manufacturing practice (GMP)-compliant polypeptide-expanded adenovirus-specific T cells after haploidentical hematopoietic stem cell transplantation. J Immunother (2014) 0.86

In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis. BMC Cancer (2005) 0.85

Common clonal T-cell origin in a patient with T-prolymphocytic leukaemia and associated cutaneous T-cell lymphomas. Br J Haematol (2003) 0.85

Skewed expression of natural-killer (NK)-associated antigens on lymphoproliferations of large granular lymphocytes (LGL). Hematol Oncol (2006) 0.84

Early TCR-beta and TCR-gamma PCR detection of T-cell clonality indicates minimal tumor disease in lymph nodes of cutaneous T-cell lymphoma: diagnostic and prognostic implications. Blood (2004) 0.84

Silencing of APAF-1 in B-CLL results in poor prognosis in the case of concomitant p53 mutation. Int J Cancer (2006) 0.83

Thermostabilization of extremophilic Dictyoglomus thermophilum GH11 xylanase by an N-terminal disulfide bridge and the effect of ionic liquid [emim]OAc on the enzymatic performance. Enzyme Microb Technol (2013) 0.83

Influence of antigen on the development of MALT lymphoma. Blood (2005) 0.83

Classical Hodgkin's lymphoma shows epigenetic features of abortive plasma cell differentiation. Haematologica (2011) 0.83

The high frequency of EBV infection in pediatric Hodgkin lymphoma is related to the classical type in Bahia, Brazil. Virchows Arch (2006) 0.83

Extranodal marginal zone B-cell lymphoma of the lacrimal gland associated with crystal-storing histiocytosis. Ophthalmology (2002) 0.82

ALDH1-positive cancer stem-like cells are enriched in nodal metastases of oropharyngeal squamous cell carcinoma independent of HPV status. Oncol Rep (2013) 0.81

No genetic evidence for involvement of Deltaretroviruses in adult patients with precursor and mature T-cell neoplasms. Retrovirology (2007) 0.81

Role of estrogen related receptor beta (ESRRB) in DFN35B hearing impairment and dental decay. BMC Med Genet (2014) 0.81

Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG). Br J Haematol (2014) 0.80

Multicenter ALK testing in non-small-cell lung cancer: results of a round robin test. J Thorac Oncol (2014) 0.80

Report: workshop on mediastinal grey zone lymphoma. Eur J Haematol Suppl (2005) 0.80

Human breath gas analysis in the screening of gestational diabetes mellitus. Diabetes Technol Ther (2012) 0.80

Elimination of dietary gluten and development of type 1 diabetes in high risk subjects. Rev Diabet Stud (2004) 0.80

Assessment of HOPE fixation in vitrectomy specimens in patients with chronic bilateral uveitis (masquerade syndrome). Graefes Arch Clin Exp Ophthalmol (2005) 0.80

Role of solvent parameters in the regeneration of cellulose from ionic liquid solutions. Biomacromolecules (2012) 0.79

Clonal T cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in the skin and blood of patients with parapsoriasis and early-stage mycosis fungoides. J Pathol (2002) 0.79

Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotype. Haematologica (2012) 0.79

Predicting cellulose solvating capabilities of acid-base conjugate ionic liquids. ChemSusChem (2013) 0.79

Switchable ionic liquids as delignification solvents for lignocellulosic materials. ChemSusChem (2014) 0.78